EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

IMPDH and GTP Metabolism in Cancer: Mechanisms, Regulation, and Translational Scope

Aki Ogawa-Iio iD, Koh Takeuchi iD, Keita Shigemi, Michelle Jane Genoveso iD, Hiroaki Niitsu iD, Iemasa Koh iD, Yusei Ota iD, Keita Yamane iD, Takao Hinoi iD, Natsuki Osaka, Masashi Oshima iD, Tomohiro Ishikawa iD und 9 weitere

Cancer Science · 2025-12 · 116 (12) · 3250-3265

DOI: 10.1111/cas.70200 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, online erschienen am 03.10.2025. Verfasst von Aki Ogawa-Iio und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: IMP Dehydrogenase, Neoplasms, Guanosine Triphosphate. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, NCI NIH HHS, Satake Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guanosine triphosphate (GTP) is increasingly recognized as a critical actor in cancer cell proliferation, yet its regulatory mechanism remains incompletely defined. A key contributor to elevated GTP levels in tumors is inosine monophosphate dehydrogenase 2 (IMPDH2), a rate‐limiting enzyme in the de novo guanine nucleotide biosynthetic pathway. Although IMPDH inhibitors, mycophenolic acid (MPA) and mycophenolate mofetil (MMF), have shown potential in cancer therapies, their success has been limited due to their immunosuppressive side effects and several unresolved regulatory mechanisms, including paradoxical control of IMPDH activity by GTP. This review provides a systematic summary of the current understanding of IMPDH biology, emphasizing its complex regulation and therapeutic relevance in cancer. We will outline key unresolved questions, including isozyme‐specific roles and mechanisms for escaping regulation, and propose mechanistic and translational strategies to design IMPDH‐targeted cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IMP DehydrogenaseNeoplasmsGuanosine TriphosphateHumansAnimalsEnzyme InhibitorsCell Proliferation

Stichwörter der Autor:innen

GTPIMPDHdrug repositioningenergy metabolismmetabolism

Substanzen

IMP DehydrogenaseGuanosine TriphosphateIMPDH2 protein, humanEnzyme Inhibitors

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
  • Cellular and Molecular Biology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki, Japan.
  • Structural Biology Research Center, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan.
  • Department of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan.
  • Department of Obstetrics and Gynecology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

ORCID-Profile: Aki Ogawa-Iio, Koh Takeuchi, Michelle Jane Genoveso, Hiroaki Niitsu, Iemasa Koh, Yusei Ota, Keita Yamane, Takao Hinoi, Masashi Oshima, Tomohiro Ishikawa, Tomoyuki Mizuno, Manabu Natsumeda, Kensuke Tateishi, Rintaro Hashizume, Susumu Goyama, Tomoharu Yasuda, Toshiya Senda, Atsuo T Sasaki

Förderung

  • Japan Agency for Medical Research and Development
  • NCI NIH HHS
  • Satake Fund
  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science
  • TERUMO LIFE SCIENCE FOUNDATION
  • Naito Foundation
  • NIGMS NIH HHS

Zitieren

APA

Ogawa-Iio, A., Takeuchi, K., Shigemi, K., Genoveso, M. J., Niitsu, H., Koh, I., Ota, Y., Yamane, K., Hinoi, T., Osaka, N., Oshima, M., Ishikawa, T., Mizuno, T., Natsumeda, M., Tateishi, K., Hashizume, R., Osuka, S., Goyama, S., Yasuda, T., …, & Sasaki, A. T. (2025). IMPDH and GTP Metabolism in Cancer: Mechanisms, Regulation, and Translational Scope. Cancer Science, 116(12), 3250-3265. https://doi.org/10.1111/cas.70200

Vancouver

Ogawa-Iio A, Takeuchi K, Shigemi K, Genoveso MJ, Niitsu H, Koh I, et al. IMPDH and GTP Metabolism in Cancer: Mechanisms, Regulation, and Translational Scope. Cancer Science. 2025;116(12):3250-3265. doi:10.1111/cas.70200

BibTeX
@article{OgawaIio2025,
  author = {Ogawa-Iio, Aki and Takeuchi, Koh and Shigemi, Keita and Genoveso, Michelle Jane and Niitsu, Hiroaki and Koh, Iemasa and Ota, Yusei and Yamane, Keita and Hinoi, Takao and Osaka, Natsuki and Oshima, Masashi and Ishikawa, Tomohiro and Mizuno, Tomoyuki and Natsumeda, Manabu and Tateishi, Kensuke and Hashizume, Rintaro and Osuka, Satoru and Goyama, Susumu and Yasuda, Tomoharu and Senda, Toshiya and Sasaki, Atsuo T},
  title = {IMPDH and GTP Metabolism in Cancer: Mechanisms, Regulation, and Translational Scope},
  journal = {Cancer Science},
  year = {2025},
  volume = {116},
  number = {12},
  pages = {3250--3265},
  doi = {10.1111/cas.70200}
}
Kostenlos starten →